Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Karizoo is a long-established Spanish manufacturer specializing in the development and distribution of pharmaceuticals—primarily small-molecule drugs such as antibiotics—and nutritional products for animal health. Founded in 1983 and now part of Alivira Animal Health since 2016, the company operates out of Caldes de Montbui (Barcelona), serving both local (European) and international markets with GMP-certified facilities. Its portfolio includes well-known antibiotic brands (e.g., Amoxicillin, Doxycycline) as well as nutraceuticals, and it exports widely across Europe, Africa, and Asia. The focus remains on improving farm animal welfare, pets’ quality-of-life, and supporting veterinarians through innovative, veterinary-specific solutions. The firm does not develop human therapeutics nor conduct clinical trials typical to human biotech/pharma companies, but rather focuses on commercialized vet pharma/nutritionals with global reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorios Karizoo.